InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
58,063.71
(
-3.49%
)
Post# of 252484
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 89
Posts 17448
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: None

Monday, 07/14/2008 2:50:31 PM

Monday, July 14, 2008 2:50:31 PM

Post# of 252484
Guess the P value.

In INGN's P3 trial, the primary endpoint had a median survival of 4.4 months for Advexin vs. 6.1 for the comparator (N=123).

In order to do some exploratory analysis (needed for PR hype) they gathered tissue samples on some of these patients.

In the tissue sampled population, the Advexin arm outperformed 5.2 months vs. 4.6 months (N=67).

What is the P value that the tissue sampled sub-population was not chosen from the ITT population at random?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up